Unknown

Dataset Information

0

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/?-catenin pathway in the normal mucosa of colorectal adenoma patients.


ABSTRACT: APC/?-catenin pathway perturbation is a common early event in colorectal carcinogenesis and is affected by calcium and vitamin D in basic science studies. To assess the effects of calcium and vitamin D on adenomatous polyposis coli (APC), ?-catenin, and E-cadherin expression in the normal appearing colorectal mucosa of sporadic colorectal adenoma patients, we conducted a randomized, double-blinded, placebo-controlled 2 × 2 factorial clinical trial. Pathology-confirmed colorectal adenoma cases were treated with 2 g/day elemental calcium and/or 800 IU/day vitamin D(3) versus placebo over 6 months (N = 92; 23/group). Overall APC, ?-catenin, and E-cadherin expression and distributions in colon crypts in normal-appearing rectal mucosa biopsies were detected by standardized automated immunohistochemistry and quantified by image analysis. In the vitamin D(3)-supplemented group relative to placebo, the proportion of APC in the upper 40% of crypts (?h APC) increased 21% (P = 0.01), ?-catenin decreased 12% (P = 0.18), E-cadherin increased 72% (P = 0.03), and the ?h APC/?-catenin ratio (APC/?-catenin score) increased 31% (P = 0.02). In the calcium-supplemented group ?h APC increased 10% (P = 0.12), ?-catenin decreased 15% (P = 0.08), and the APC/?-catenin score increased 41% (P = 0.01). In the calcium/vitamin D(3)-supplemented group, ?-catenin decreased 11% (P = 0.20), E-cadherin increased 51% (P = 0.08), and the APC/?-catenin score increased 16% (P = 0.26). These results support (i) that calcium and vitamin D modify APC, ?-catenin, and E-cadherin expression in humans in directions hypothesized to reduce risk for colorectal neoplasms, (ii) calcium and vitamin D as potential chemopreventive agents against colorectal neoplasms, and (iii) the potential of APC, ?-catenin, and E-cadherin expression as modifiable, preneoplastic risk biomarkers for colorectal neoplasms.

PROVIDER: S-EPMC3466388 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5586148 | BioStudies
| S-EPMC2915628 | BioStudies
| S-EPMC3064476 | BioStudies
| S-EPMC6296527 | BioStudies
| S-EPMC2712935 | BioStudies
2015-01-01 | S-EPMC4471889 | BioStudies
| S-EPMC4484733 | BioStudies
| S-EPMC4417398 | BioStudies
| S-EPMC7074366 | BioStudies
| S-EPMC2923074 | BioStudies